Goodbody Health Share Price Canadian Securities Exchange
Equities
SWEL
CA3821591011
Pharmaceuticals
Sales 2020 | 1.99M 2.51M 3.43M 199M | Sales 2021 | 17.06M 21.43M 29.31M 1.71B | Capitalization | 13.76M 17.28M 23.64M 1.38B |
---|---|---|---|---|---|
Net income 2020 | -4M -5.03M -6.87M -400M | Net income 2021 | -2M -2.51M -3.44M -200M | EV / Sales 2020 | 5.41 x |
Net cash position 2020 | 1.37M 1.72M 2.36M 137M | Net cash position 2021 | 5.73M 7.2M 9.85M 573M | EV / Sales 2021 | 0.47 x |
P/E ratio 2020 |
-1.4
x | P/E ratio 2021 |
-5.64
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 70.26% |
Managers | Title | Age | Since |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 25/01/21 |
Geremy Thomas
FOU | Founder | 64 | 13/02/11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 13/02/11 |
George Thomas
CEO | Chief Executive Officer | 35 | 25/01/21 |
Anne Tew
SEC | Corporate Secretary | - | 31/10/18 |
1st Jan change | Capi. | |
---|---|---|
+43.17% | 6.16B | |
-14.69% | 4.46B | |
-8.17% | 3.27B | |
+6.95% | 3.2B | |
-1.76% | 2.6B | |
+50.20% | 1.98B | |
-7.85% | 1.7B | |
-0.40% | 1.66B | |
-9.91% | 1.61B |